Veradermics (MANE) Stock Price & Analysis
MANE$145.37+1.54 +1.07%
$6.07B
Market Cap
-51.74
P/E
30.16
Forward P/E
47
Score
Veradermics (MANE) Stock Price & Analysis
MANE price $145.37 +1.54 +1.07%
- Ticker
- MANE
- Price
- $145.37
- Change
- +1.54 +1.07%
- Market cap ?
- $6.07B
- P/E ?
- -51.74
- Forward P/E ?
- 30.16
- Dividend yield ?
- 0.00%
- Beta ?
- 1.23
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 47
- Value
- 30
- Quality
- 49
- Growth
- 63
Stocklytics score rationale: value 30, quality 49, growth 63.
Financials
| 2023 | 2024 | 2025 |
|---|---|---|
| 0 | 0 | 0 |
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss…
Insights · Dividends · Forecast · Financials · Learn